SEC Form 4 · accession 0001633970-15-000041
Catalent, Inc. · CTLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Houlton
Officer — See Remarks
Period of report
Sep 2, 2015
Accepted (ET)
Sep 4, 2015 · 5:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596783
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stockF1 | $18.57 | Sep 2, 2015 | A | 1,176 | A | May 25, 2013 | May 25, 2022 | Common Stock | 1,176 | 3,528 | D |
| Options to purchase common stockF2 | $18.71 | Sep 2, 2015 | A | 6,426 | A | Jun 25, 2014 | Jun 25, 2023 | Common Stock | 6,426 | 12,852 | D |
Explanation of responses
- F1On May 25, 2012, the reporting person was granted an option to purchase 5,880 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2013, 2014, 2015, 2016 and 2017. The performance criteria for 2013, 2014 and 2015 were met, resulting in vesting of the option as to 3,528 shares in the aggregate.
- F2On June 25, 2013, the reporting person was granted an option to purchase 32,130 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2014, 2015, 2016, 2017 and 2018. The performance criteria for 2014 and 2015 were met, resulting in vesting of the option as to 12,852 shares in the aggregate.
Remarks
Group President - Development & Clinical Services